Avalo Therapeutics, Inc. ($AVTX)
Filing Information
| Accession Number | 0001918845-26-000012 |
|---|---|
| Form Type | 4 |
| Filing Date | May 19, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
9,000
Total Value
$94,230.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | May 15, 2026 | Exercise/Conversion | 3,000 | $12.65 | $37,950.00 | 6,622 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 15, 2026 | Sale | 3,000 | $18.76 | $56,280.00 | 3,622 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | May 15, 2026 | Exercise/Conversion | 3,000 | $0.00 | $0.00 | 128,625 | Direct | โ | View Details |